Niclosamide, an antihelmintic drug, enhances efficacy of PD-1/PD-L1 immune checkpoint blockade in non-small cell lung cancer

RT @renesugar: Niclosamide, ..., enhances efficacy of PD-1/PD-L1 immune checkpoint blockade in non-small cell lung cancer https://t.co/2t9…

Niclosamide, ..., enhances efficacy of PD-1/PD-L1 immune checkpoint blockade in non-small cell lung cancer https://t.co/2t9oDFq927 "PD-L1 downregulation induced by niclosamide is related to the inhibition of STAT3 phosphorylation and its binding to PD-L1

@pash22 @VPrasadMDMPH @audreyamadean @oncology_bg Take a look at this study in mice, where niclosamide alone was more effective than PD-1 blockade and synergistic with it: https://t.co/Bn6LPdzutV. This is the only human trial that I know of: https://t.co/

RT @jitcancer: #JITC Research: Niclosamide, an antihelmintic drug, enhances efficacy of PD-1/PD-L1 immune checkpoint blockade in non-small…